IBDEI07P ; ; 06-AUG-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;AUG 06, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10155,1,1,0)
 ;;=1^V44.7
 ;;^UTILITY(U,$J,358.3,10155,1,8,0)
 ;;=8^Artificial Vagina Status
 ;;^UTILITY(U,$J,358.3,10155,2)
 ;;=^295455
 ;;^UTILITY(U,$J,358.3,10156,0)
 ;;=V44.8^^68^597^1
 ;;^UTILITY(U,$J,358.3,10156,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,10156,1,1,0)
 ;;=1^V44.8
 ;;^UTILITY(U,$J,358.3,10156,1,8,0)
 ;;=8^Artif Open Status Nec
 ;;^UTILITY(U,$J,358.3,10156,2)
 ;;=^295456
 ;;^UTILITY(U,$J,358.3,10157,0)
 ;;=V44.9^^68^597^2
 ;;^UTILITY(U,$J,358.3,10157,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,10157,1,1,0)
 ;;=1^V44.9
 ;;^UTILITY(U,$J,358.3,10157,1,8,0)
 ;;=8^Artif Open Status Nos
 ;;^UTILITY(U,$J,358.3,10157,2)
 ;;=^295457
 ;;^UTILITY(U,$J,358.3,10158,0)
 ;;=V10.72^^68^598^19
 ;;^UTILITY(U,$J,358.3,10158,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,10158,1,1,0)
 ;;=1^V10.72
 ;;^UTILITY(U,$J,358.3,10158,1,8,0)
 ;;=8^Hx-Hodgkin'S Disease
 ;;^UTILITY(U,$J,358.3,10158,2)
 ;;=^295237
 ;;^UTILITY(U,$J,358.3,10159,0)
 ;;=V10.71^^68^598^22
 ;;^UTILITY(U,$J,358.3,10159,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,10159,1,1,0)
 ;;=1^V10.71
 ;;^UTILITY(U,$J,358.3,10159,1,8,0)
 ;;=8^Hx-Lymphosarcoma
 ;;^UTILITY(U,$J,358.3,10159,2)
 ;;=^295236
 ;;^UTILITY(U,$J,358.3,10160,0)
 ;;=V10.05^^68^598^5
 ;;^UTILITY(U,$J,358.3,10160,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,10160,1,1,0)
 ;;=1^V10.05
 ;;^UTILITY(U,$J,358.3,10160,1,8,0)
 ;;=8^Hx Of Colonic Malignancy
 ;;^UTILITY(U,$J,358.3,10160,2)
 ;;=^295207
 ;;^UTILITY(U,$J,358.3,10161,0)
 ;;=V10.03^^68^598^17
 ;;^UTILITY(U,$J,358.3,10161,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,10161,1,1,0)
 ;;=1^V10.03
 ;;^UTILITY(U,$J,358.3,10161,1,8,0)
 ;;=8^Hx-Esophageal Malignancy
 ;;^UTILITY(U,$J,358.3,10161,2)
 ;;=^295205
 ;;^UTILITY(U,$J,358.3,10162,0)
 ;;=V10.07^^68^598^10
 ;;^UTILITY(U,$J,358.3,10162,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,10162,1,1,0)
 ;;=1^V10.07
 ;;^UTILITY(U,$J,358.3,10162,1,8,0)
 ;;=8^Hx Of Liver Malignancy
 ;;^UTILITY(U,$J,358.3,10162,2)
 ;;=^295209
 ;;^UTILITY(U,$J,358.3,10163,0)
 ;;=V10.06^^68^598^30
 ;;^UTILITY(U,$J,358.3,10163,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,10163,1,1,0)
 ;;=1^V10.06
 ;;^UTILITY(U,$J,358.3,10163,1,8,0)
 ;;=8^Hx-Rectal   Anal Malign
 ;;^UTILITY(U,$J,358.3,10163,2)
 ;;=^295208
 ;;^UTILITY(U,$J,358.3,10164,0)
 ;;=V10.04^^68^598^7
 ;;^UTILITY(U,$J,358.3,10164,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,10164,1,1,0)
 ;;=1^V10.04
 ;;^UTILITY(U,$J,358.3,10164,1,8,0)
 ;;=8^Hx Of Gastric Malignancy
 ;;^UTILITY(U,$J,358.3,10164,2)
 ;;=^295206
 ;;^UTILITY(U,$J,358.3,10165,0)
 ;;=V10.09^^68^598^8
 ;;^UTILITY(U,$J,358.3,10165,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,10165,1,1,0)
 ;;=1^V10.09
 ;;^UTILITY(U,$J,358.3,10165,1,8,0)
 ;;=8^Hx Of Gi Malignancy Nec
 ;;^UTILITY(U,$J,358.3,10165,2)
 ;;=^295210
 ;;^UTILITY(U,$J,358.3,10166,0)
 ;;=V10.01^^68^598^13
 ;;^UTILITY(U,$J,358.3,10166,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,10166,1,1,0)
 ;;=1^V10.01
 ;;^UTILITY(U,$J,358.3,10166,1,8,0)
 ;;=8^Hx Of Tongue Malignancy
 ;;^UTILITY(U,$J,358.3,10166,2)
 ;;=^295203
 ;;^UTILITY(U,$J,358.3,10167,0)
 ;;=V10.02^^68^598^28
 ;;^UTILITY(U,$J,358.3,10167,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,10167,1,1,0)
 ;;=1^V10.02
 ;;^UTILITY(U,$J,358.3,10167,1,8,0)
 ;;=8^Hx-Oral/Pharynx Malg Nec
 ;;^UTILITY(U,$J,358.3,10167,2)
 ;;=^295204
 ;;^UTILITY(U,$J,358.3,10168,0)
 ;;=V10.22^^68^598^27
 ;;^UTILITY(U,$J,358.3,10168,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,10168,1,1,0)
 ;;=1^V10.22
 ;;^UTILITY(U,$J,358.3,10168,1,8,0)
 ;;=8^Hx-Nose/Ear/Sinus Malig
 ;;^UTILITY(U,$J,358.3,10168,2)
 ;;=^295215
 ;;^UTILITY(U,$J,358.3,10169,0)
 ;;=V10.11^^68^598^14
 ;;^UTILITY(U,$J,358.3,10169,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,10169,1,1,0)
 ;;=1^V10.11
 ;;^UTILITY(U,$J,358.3,10169,1,8,0)
 ;;=8^Hx-Bronchogenic Malignan
 ;;^UTILITY(U,$J,358.3,10169,2)
 ;;=^295211
 ;;^UTILITY(U,$J,358.3,10170,0)
 ;;=V10.12^^68^598^33
 ;;^UTILITY(U,$J,358.3,10170,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,10170,1,1,0)
 ;;=1^V10.12
 ;;^UTILITY(U,$J,358.3,10170,1,8,0)
 ;;=8^Hx-Tracheal Malignancy
 ;;^UTILITY(U,$J,358.3,10170,2)
 ;;=^295212
 ;;^UTILITY(U,$J,358.3,10171,0)
 ;;=V10.21^^68^598^21
 ;;^UTILITY(U,$J,358.3,10171,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,10171,1,1,0)
 ;;=1^V10.21
 ;;^UTILITY(U,$J,358.3,10171,1,8,0)
 ;;=8^Hx-Laryngeal Malignancy
 ;;^UTILITY(U,$J,358.3,10171,2)
 ;;=^295214
 ;;^UTILITY(U,$J,358.3,10172,0)
 ;;=V10.29^^68^598^20
 ;;^UTILITY(U,$J,358.3,10172,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,10172,1,1,0)
 ;;=1^V10.29
 ;;^UTILITY(U,$J,358.3,10172,1,8,0)
 ;;=8^Hx-Intrathoracic Mal Nec
 ;;^UTILITY(U,$J,358.3,10172,2)
 ;;=^295216
 ;;^UTILITY(U,$J,358.3,10173,0)
 ;;=V10.87^^68^598^12
 ;;^UTILITY(U,$J,358.3,10173,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,10173,1,1,0)
 ;;=1^V10.87
 ;;^UTILITY(U,$J,358.3,10173,1,8,0)
 ;;=8^Hx Of Thyroid Malignancy
 ;;^UTILITY(U,$J,358.3,10173,2)
 ;;=^295245
 ;;^UTILITY(U,$J,358.3,10174,0)
 ;;=V10.51^^68^598^1
 ;;^UTILITY(U,$J,358.3,10174,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,10174,1,1,0)
 ;;=1^V10.51
 ;;^UTILITY(U,$J,358.3,10174,1,8,0)
 ;;=8^Hx Of Bladder Malignancy
 ;;^UTILITY(U,$J,358.3,10174,2)
 ;;=^295228
 ;;^UTILITY(U,$J,358.3,10175,0)
 ;;=V10.52^^68^598^9
 ;;^UTILITY(U,$J,358.3,10175,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,10175,1,1,0)
 ;;=1^V10.52
 ;;^UTILITY(U,$J,358.3,10175,1,8,0)
 ;;=8^Hx Of Kidney Malignancy
 ;;^UTILITY(U,$J,358.3,10175,2)
 ;;=^295229
 ;;^UTILITY(U,$J,358.3,10176,0)
 ;;=V10.46^^68^598^29
 ;;^UTILITY(U,$J,358.3,10176,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,10176,1,1,0)
 ;;=1^V10.46
 ;;^UTILITY(U,$J,358.3,10176,1,8,0)
 ;;=8^Hx-Prostatic Malignancy
 ;;^UTILITY(U,$J,358.3,10176,2)
 ;;=^295224
 ;;^UTILITY(U,$J,358.3,10177,0)
 ;;=V10.47^^68^598^32
 ;;^UTILITY(U,$J,358.3,10177,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,10177,1,1,0)
 ;;=1^V10.47
 ;;^UTILITY(U,$J,358.3,10177,1,8,0)
 ;;=8^Hx-Testicular Malignancy
 ;;^UTILITY(U,$J,358.3,10177,2)
 ;;=^295225
 ;;^UTILITY(U,$J,358.3,10178,0)
 ;;=V10.49^^68^598^23
 ;;^UTILITY(U,$J,358.3,10178,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,10178,1,1,0)
 ;;=1^V10.49
 ;;^UTILITY(U,$J,358.3,10178,1,8,0)
 ;;=8^Hx-Male Genit Malig Nec
 ;;^UTILITY(U,$J,358.3,10178,2)
 ;;=^295226
 ;;^UTILITY(U,$J,358.3,10179,0)
 ;;=V10.45^^68^598^24
 ;;^UTILITY(U,$J,358.3,10179,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,10179,1,1,0)
 ;;=1^V10.45
 ;;^UTILITY(U,$J,358.3,10179,1,8,0)
 ;;=8^Hx-Male Genit Malig Nos
 ;;^UTILITY(U,$J,358.3,10179,2)
 ;;=^295223
 ;;^UTILITY(U,$J,358.3,10180,0)
 ;;=V10.3^^68^598^4
 ;;^UTILITY(U,$J,358.3,10180,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,10180,1,1,0)
 ;;=1^V10.3
 ;;^UTILITY(U,$J,358.3,10180,1,8,0)
 ;;=8^Hx Of Breast Malignancy
 ;;^UTILITY(U,$J,358.3,10180,2)
 ;;=^295217
 ;;^UTILITY(U,$J,358.3,10181,0)
 ;;=V10.41^^68^598^15
 ;;^UTILITY(U,$J,358.3,10181,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,10181,1,1,0)
 ;;=1^V10.41
 ;;^UTILITY(U,$J,358.3,10181,1,8,0)
 ;;=8^Hx-Cervical Malignancy
 ;;^UTILITY(U,$J,358.3,10181,2)
 ;;=^295219
 ;;^UTILITY(U,$J,358.3,10182,0)
 ;;=V10.42^^68^598^34
 ;;^UTILITY(U,$J,358.3,10182,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,10182,1,1,0)
 ;;=1^V10.42
 ;;^UTILITY(U,$J,358.3,10182,1,8,0)
 ;;=8^Hx-Uterus Malignancy Nec
 ;;^UTILITY(U,$J,358.3,10182,2)
 ;;=^295220
 ;;^UTILITY(U,$J,358.3,10183,0)
 ;;=V10.43^^68^598^11
 ;;^UTILITY(U,$J,358.3,10183,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,10183,1,1,0)
 ;;=1^V10.43
 ;;^UTILITY(U,$J,358.3,10183,1,8,0)
 ;;=8^Hx Of Ovarian Malignancy
 ;;^UTILITY(U,$J,358.3,10183,2)
 ;;=^295221
 ;;^UTILITY(U,$J,358.3,10184,0)
 ;;=V10.44^^68^598^18
 ;;^UTILITY(U,$J,358.3,10184,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,10184,1,1,0)
 ;;=1^V10.44
 ;;^UTILITY(U,$J,358.3,10184,1,8,0)
 ;;=8^Hx-Female Genit Malg Nec
 ;;^UTILITY(U,$J,358.3,10184,2)
 ;;=^295222
 ;;^UTILITY(U,$J,358.3,10185,0)
 ;;=V10.81^^68^598^2
 ;;^UTILITY(U,$J,358.3,10185,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,10185,1,1,0)
 ;;=1^V10.81
 ;;^UTILITY(U,$J,358.3,10185,1,8,0)
 ;;=8^Hx Of Bone Malignancy
 ;;^UTILITY(U,$J,358.3,10185,2)
 ;;=^295239
 ;;^UTILITY(U,$J,358.3,10186,0)
 ;;=V10.82^^68^598^25
 ;;^UTILITY(U,$J,358.3,10186,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,10186,1,1,0)
 ;;=1^V10.82
 ;;^UTILITY(U,$J,358.3,10186,1,8,0)
 ;;=8^Hx-Malig Skin Melanoma
 ;;^UTILITY(U,$J,358.3,10186,2)
 ;;=^295240
 ;;^UTILITY(U,$J,358.3,10187,0)
 ;;=V10.83^^68^598^31
 ;;^UTILITY(U,$J,358.3,10187,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,10187,1,1,0)
 ;;=1^V10.83
 ;;^UTILITY(U,$J,358.3,10187,1,8,0)
 ;;=8^Hx-Skin Malignancy Nec
 ;;^UTILITY(U,$J,358.3,10187,2)
 ;;=^295241
 ;;^UTILITY(U,$J,358.3,10188,0)
 ;;=V10.84^^68^598^6
 ;;^UTILITY(U,$J,358.3,10188,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,10188,1,1,0)
 ;;=1^V10.84
 ;;^UTILITY(U,$J,358.3,10188,1,8,0)
 ;;=8^Hx Of Eye Malignancy
 ;;^UTILITY(U,$J,358.3,10188,2)
 ;;=^295242
 ;;^UTILITY(U,$J,358.3,10189,0)
 ;;=V10.85^^68^598^3
 ;;^UTILITY(U,$J,358.3,10189,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,10189,1,1,0)
 ;;=1^V10.85
 ;;^UTILITY(U,$J,358.3,10189,1,8,0)
 ;;=8^Hx Of Brain Malignancy
 ;;^UTILITY(U,$J,358.3,10189,2)
 ;;=^295243
 ;;^UTILITY(U,$J,358.3,10190,0)
 ;;=V10.86^^68^598^26
 ;;^UTILITY(U,$J,358.3,10190,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,10190,1,1,0)
 ;;=1^V10.86
 ;;^UTILITY(U,$J,358.3,10190,1,8,0)
 ;;=8^Hx-Malign Nerve Syst Nec
 ;;^UTILITY(U,$J,358.3,10190,2)
 ;;=^295244
 ;;^UTILITY(U,$J,358.3,10191,0)
 ;;=V10.88^^68^598^16
 ;;^UTILITY(U,$J,358.3,10191,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,10191,1,1,0)
 ;;=1^V10.88
 ;;^UTILITY(U,$J,358.3,10191,1,8,0)
 ;;=8^Hx-Endocrine Malign Nec
 ;;^UTILITY(U,$J,358.3,10191,2)
 ;;=^295246
 ;;^UTILITY(U,$J,358.3,10192,0)
 ;;=A4220^^69^599^1^^^^1
 ;;^UTILITY(U,$J,358.3,10192,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10192,1,1,0)
 ;;=1^A4220
